San Diego Biotech’s ‘Molecular Glue’ Hits First Kidney Cancer Patient
San Diego biotech Neomorph has dosed the first patient in a Phase 1/2 trial of NEO‑811, a molecular glue for clear‑cell kidney cancer, after landing multibillion‑dollar pharma deals. Early safety and activity readouts will be the near‑term test.
University of Cincinnati Pioneers 'Brain Cancer-On-A-Chip' – Groundbreaking Wafer Technology to Weaponize Immune System Against Tumors
University of Cincinnati Cancer Center researchers aim to develop new glioblastoma treatments using "glioblastoma-on-a-chip" and immunostimulatory wafers following surgery.
Seattle Giant Amazon Stumbled On Huge Cache Of Child Sex Abuse Images In AI Data
Bloomberg reports Amazon flagged hundreds of thousands of suspected child-sex-abuse images in datasets used for AI training; child-safety groups say missing provenance makes many reports inactionable.
Fort Collins 11-Year-Old Skates Home After Ultra-Rare Heart-Liver Transplant
An 11-year-old from Fort Collins returned home after a rare combined heart-liver transplant at Children's Hospital Colorado. Surgeons and the family credited a speedy donor match and a coordinated, multidisciplinary team.












